Title:
VX-950を含む剤形およびそれらの投与量レジメン
Document Type and Number:
Japanese Patent JP2008518943
Kind Code:
A
Abstract:
The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.
Inventors:
Ju Hui-May
Energy Ette
Lindsey McNair
John Alam
Energy Ette
Lindsey McNair
John Alam
Application Number:
JP2007539241A
Publication Date:
June 05, 2008
Filing Date:
October 31, 2005
Export Citation:
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED
International Classes:
A61K38/00; A61K31/13; A61K31/7056; A61K38/21; A61K38/22; A61K45/00; A61P1/16; A61P3/06; A61P31/14; A61P43/00
Foreign References:
| WO2005123076A2 | 2005-12-29 | |||
| WO2005042570A1 | 2005-05-12 |
Other References:
JPN6011040838; Ｊ Ｂｉｏｌ Ｃｈｅｍ．， ２７９［１７］ （２００４ Ａｐｒ） ｐ．１７５０８-１４． Ｅｐｕｂ ２００４ Ｆｅｂ ６．
JPN6011040839; Ｎａｔｕｒｅ， ４２６ （２００３） ｐ．１８６-１８９
JPN6011040842; 内科， ９３［３］ （２００４．０３．０１） ｐ．４８２-４８６
JPN5007019018; ＴＡＮ Ｓ-Ｌ: ＣＵＲＲＥＮＴ ＯＰＩＮＩＯＮ ＩＮ ＰＨＡＲＭＡＣＯＬＯＧＹ Ｖ４ Ｎ５, 200410, Ｐ４６５-４７０, ＥＬＳＥＶＩＥＲ ＳＣＩＥＮＣＥ ＰＵＢＬＩＳＨＥＲＳ
JPN5007019017; 'ＶＥＲＴＥＸ ＰＨＡＲＭＡＣＥＵＴＩＣＡＬＳ ＰＲＥＳＳ ＲＥＬＥＡＳＥ' ［ＯＮＬＩＮＥ］ , 20040907
JPN5007019019; 'ＰＲＥＣＬＩＮＩＣＡＬ ＤＡＴＡ ＳＵＧＧＥＳＴ ＰＯＴＥＮＴＩＡＬ ＦＯＲ ＯＲＡＬ ＣＯＭＢＩＮＡＴＩＯＮ ＡＰＰＲＯＡＣＨＥＳ ＦＯＲ ＨＣＶ' ［ＯＮＬＩＮＥ］ , 20040531
JPN6011040839; Ｎａｔｕｒｅ， ４２６ （２００３） ｐ．１８６-１８９
JPN6011040842; 内科， ９３［３］ （２００４．０３．０１） ｐ．４８２-４８６
JPN5007019018; ＴＡＮ Ｓ-Ｌ: ＣＵＲＲＥＮＴ ＯＰＩＮＩＯＮ ＩＮ ＰＨＡＲＭＡＣＯＬＯＧＹ Ｖ４ Ｎ５, 200410, Ｐ４６５-４７０, ＥＬＳＥＶＩＥＲ ＳＣＩＥＮＣＥ ＰＵＢＬＩＳＨＥＲＳ
JPN5007019017; 'ＶＥＲＴＥＸ ＰＨＡＲＭＡＣＥＵＴＩＣＡＬＳ ＰＲＥＳＳ ＲＥＬＥＡＳＥ' ［ＯＮＬＩＮＥ］ , 20040907
JPN5007019019; 'ＰＲＥＣＬＩＮＩＣＡＬ ＤＡＴＡ ＳＵＧＧＥＳＴ ＰＯＴＥＮＴＩＡＬ ＦＯＲ ＯＲＡＬ ＣＯＭＢＩＮＡＴＩＯＮ ＡＰＰＲＯＡＣＨＥＳ ＦＯＲ ＨＣＶ' ［ＯＮＬＩＮＥ］ , 20040531
Attorney, Agent or Firm:
Mitsuo Tanaka
Takuji Yamada
Mitsutaka Iwasaki
Takuji Yamada
Mitsutaka Iwasaki